Hospira to reduce workforce by 10%
According to Hospira, the majority of reductions will occur in the next 12 months. The company will help prepare employees for the transitions through the provision of assistance
Health innovation platform developer Aditxt and its fully owned subsidiary Ignite Proteomics have announced their plans for a business combination with a strategic partner that values the latter at an implied equity value of nearly $150m.
“In recent years, life-saving diagnostic lab tests have been developed that can help doctors clarify inconclusive diagnoses and tailor treatments according to individual patient’s DNA and the specific